Heparin fix leads to new concerns
Baltimore Sun, May 16, 2008
Efforts to make the blood thinner heparin safer, and to replace supplies that were depleted by a major recall, have meant new safety concerns for hospitals, heart clinics and dialysis centers that use it. The drug was recalled in February after contamination during production in China led to as many as 81 deaths in the United States. Its leading maker has suspended manufacture of most of its heparin products. The resulting shortage of heparin means heparin from new suppliers is arriving in different quantities and strengths than medical staffs are accustomed to, and pharmacists and others worry that patients may be vulnerable to receiving improper doses.
- mHealth Tackles Readmissions
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Targeting Self-Insured Populations
- MA an Insurance Proving Ground for Providers
- Proton Beam Therapy Poised for Growth in US
- Sharp HealthCare Leaves Pioneer ACO Program
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'